Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Down Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Down Syndrome (Genetic Disorders) pipeline landscape. Down syndrome is a genetic disorder that causes lifelong mental retardation, developmental delays and ... Read More
-
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hepatic Encephalopathy (Gastrointestinal) pipeline landscape. Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no ... Read More
-
Venous Leg Ulcers (Crural ulcer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... ulcer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Venous Leg Ulcers (Crural Ulcer) (Dermatology) pipeline landscape. Venous leg ulcers develop when persistently ... Read More
-
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The latest report Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and ... Read More
-
Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hidradenitis Suppurativa (Dermatology) pipeline landscape. Hidradenitis suppurativa is a chronic skin condition that features pea-sized to marble-sized lumps under the ... Read More
-
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) pipeline Target constitutes close to 20 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. The ... Read More
-
Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hyperalgesia (Central Nervous System) pipeline landscape. Hyperalgesia is an increase in pain response. Predisposing factors include long term opioid usage, inflammation, damage ... Read More
-
Tourette Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Tourette Syndrome (Central Nervous System) pipeline landscape. Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements ... Read More
-
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... recently published report 'Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update'; Hepcidin ... Read More
-
Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... beta 1 (TGF-β1) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by the TGFB1 gene. It plays an important role in bone remodeling as it is a potent stimulator ... Read More
-
Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Intermittent Claudication (Cardiovascular) pipeline landscape. Intermittent claudication is caused by narrowing or blockage in the main artery that takes blood ... Read More
-
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Dilated Cardiomyopathy (Cardiovascular) pipeline landscape. Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is ... Read More
-
Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline landscape. Nasopharyngitis also known as common cold is an infectious, ... Read More
-
Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. ... Read More
-
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Summary According to the recently published report 'Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, ... Read More
-
Transcriptomics Market by Type (Consumables, Instruments, Software, and Services), Technology (Microarrays, Qpcr, and Sequencing Technology), Application (Drug Discovery, Diagnostics & Disease Profiling, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.Transcriptomics is the collection and study of RNA present in different types ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More
-
2022 Global Forecast for Live Cell Encapsulation (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The pharmacogenomics market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is estimated to ... Read More
-
2022 Global: Drug Discovery Services - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
2022 Global Forecast for Immunotherapy Drugs (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global: Drug Discovery Informatics - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
Bioinformatics Market (Platforms, Tools, and Services: Platforms [Sequence Manipulation Platforms, Sequence Alignment Platforms, Structural Analysis Platforms, and Sequence Analysis Platforms], Tools [General Knowledge Management Tools and Specialized Knowledge Management Tools], and Services [Data Analysis, Sequencing Services, Database & Management, and Other Services]; and Application: Preventive Medicine, Molecular Medicine, Gene Therapy, Drug Development, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Services, Database & Management, and Other Services]; and Application: Preventive Medicine, Molecular Medicine, Gene Therapy, Drug Development, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Bioinformatics Market – Scope of ... Read More
-
Metabolomics Global Market Report 2022 Including: 1) By Product & Service: Metabolomics Instruments; Metabolomics Bioinformatics Tools & Services 2) By Application: Biomarker Discovery; Drug Discovery; Toxicology Testing; Nutrigenomics; Functional Genomics; Personalized Medicine; Others 3) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors of Metabolism; Others 4) By Metabolomics Instruments: Separation Techniques; Detection Techniques 5) By Metabolomics Bioinformatics Tools & Services: Bioinformatics Tools and Database; Bioinformatics Services Covering: Human Metabolome Technologies; Metabolon; Bio-Rad Laboratories; Bruker; Agilent Technologies; Thermo Fisher; Waters
... which is experiencing strong growth. The report gives a guide to the metabolomics market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the ... Read More
-
Spatial Genomics and Transcriptomics Market by Technique (Spatial Transcriptomics, and Spatial Genomics Analysis), Product Type (Instruments, Consumables, and Software), Application, (Translational Research, and Drug Discovery & Development) and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Research Organizations, and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global spatial genomics and transcriptomics market was valued at $626.9 million in 2020 and is projected to reach $2,159.61 million ... Read More
Research Assistance
